
We invite journalists to contact us for interviews and information about the Access Campaign’s work.
Morag McKenzie
Communications Officer
Berlin, Germany
Mobile: +49 172 525 1319
Email: morag.mckenzie@berlin.msf.org
Follow us on Twitter
MSF Access campaign on Twitter: @msf_access
MSF Access Campaign team members on Twitter
Latest press releases
Latest press releases
Press release
|
MSF calls for increased global investment ahead of World NTD Day
Press release
|
MSF warns that supply delays of critical TB test will cost lives
@msf_access on Twitter
MSF Access Campaign
@MSF_access
MSF representatives will speak at the @WHO Executive Board 152nd session this week on the following topics: ☑️ Strengthening diagnostics capacity☑️ Strengthening clinical trials☑️ Substandard and falsified medical products #EB152 msfaccess.org/msf-statements…
16:30 - 01 Feb 2023
MSF Access Campaign
@MSF_access
Today is World Neglected Tropical Disease (NTD) Day. Despite donor commitments made last year, NTDs may slide into further neglect due to insufficient funding. MSF demands a better global response to #BeatNTDs 📣 msfaccess.org/msf-calls-incr…
13:18 - 30 Jan 2023
MSF Access Campaign
@MSF_access

Our team of doctors, pharmacists, lawyers, policy & advocacy experts have been working hard to gain equitable access to medicines. To kickstart 2023, we're excited to share our plans for the year! 🚀🧵 #MedicinesShouldntBeALuxury
18:10 - 27 Jan 2023
MSF Access Campaign
@MSF_access
Read how Dilaram’s life was transformed when she took part in the #TB PRACTECAL clinical trials and helped us deliver a groundbreaking new treatment for people with drug-resistant TB. ow.ly/8Xq750MyRg0
21:01 - 24 Jan 2023
MSF Access Campaign
@MSF_access
New year, new hope! In 2023 we are looking forward to sharing how #TB PRACTECAL is starting to transform people’s lives with a groundbreaking new treatment for drug-resistant TB. ow.ly/xXSU50MyR2E
18:15 - 24 Jan 2023
MSF Access Campaign
@MSF_access

In 2022 we broke the news about a successful new treatment for people drug-resistant TB.In 2023 we look forward to sharing the experiences of the people who are benefiting from #TB PRACTECAL.Read Dilaram’s story on our blog. msf-access.medium.com/new-shorter-tr…
15:52 - 24 Jan 2023